A researcher at the University of Alberta in Edmonton will be receiving one of the most prestigious awards in the country.
Lorne Tyrrell, who is a professor in the institution’s Department of Medical Microbiology and immunology, helped to discover the first oral medication that can be used to treat hepatitis B in 1998. In 2011, he was inducted into the Canadian Medical Hall of Fame, and this year, he will be the recipient of the 2015 Killam Prize for Health Sciences due to his efforts to study and help find treatments for viral hepatitis.
The award will be presented to him in Ottawa’s Rideau Hall in a ceremony to be held on May 12. Along with this, he will receive a $100,000 prize.
A firm that provides printing services will be able to create an award certificate to go with the prize. Prof. Tyrrell remarked that he is overwhelmed and gratified at being selected to receive the honor. He has been working in the field of virology for many years, and has spent 30 of them studying diseases of the liver.
The dean of the his institution’s Faculty of Medicine and Dentistry noted that he feels the he richly deserves the accolade, as his work has helped to improve the lives of people all over the world who have contracted hepatitis and other diseases of the liver.
